| Thermo Fisher–General Electric: investment, 201401–201403 acquisition $1.06b cell culture media + sera + gene modulation + magnetic beads businesses |
2014-01-06 |
| AstraZeneca–Probiodrug: CDK9 inhibitors, 201401 acquisition €na of CDK9 inhibitor program by AstraZeneca |
2014-01-03 |
| Aettis–Medigene: investment, 2014 spin-off of Aettis from Catherex with Medigene receiving 39% shareholding in Aettis |
2014-01-01 |
| CeeTox–Cyprotex: investment, 201401 acquisition of assets + business of CeeTox by Cyprotex |
2014-01-01 |
| Dinkelberg Analytics–Altmann Analytik: investment, 201401 acquisition |
2014-01-01 |
| Helmholtz–NN: mass spectrometer, 2014 supply PLANNED installation of SIMS at UFZ in Leipzig |
2014-01-01 |
| Horizon Discovery–ERS Genomics: CRISPR technology, 2014– license ww non-excl to Horizon |
2014-01-01 |
| Laboratorios LETI–Curetis: Unyvero system, 201401– distribution excl in Spain + Portugal by Laboratorios LETI |
2014-01-01 |
| Padlock Therapeutics–Evotec: drug discovery services, 201401–201412 collab to deliver multiple PAD inhibitor development candidates |
2014-01-01 |
| Peqlab–VWR International: investment, 2014 acquisition of Peqlab Biotechnologie GmbH inkl Clemens GmbH by VWR |
2014-01-01 |
| Proteome Sciences–Thermo Fisher: mass spectrometer, 201401 supply installation Orbitrap Fusion MS as part of license deal w Thermo |
2014-01-01 |
| Provecs–Cevec: rec protein production technology, 2014– license to CAP GT technology for cancer immunotherapy |
2014-01-01 |
| Rebiotix–SEVERAL: investment, 2014 financing round Series B $25m |
2014-01-01 |
| Sirion Biotech–LaVoieHealthScience: public relations, 2014– supply service US PR/IR |
2014-01-01 |
| Tusk Therapeutics–Droia Oncology Ventures: investment, 201809 existent majority shareholder + founding investor |
2014-01-01 |
| Biognosys–OTHER: credit, 201312 convertible loan $1m |
2013-12-31 |
| Optronik–Carl Zeiss: investment, 201312 acquisition 100% of former excl Turkish distribution partner by Carl Zeiss Meditec |
2013-12-31 |
| Sirion Biotech–Cevec: cell lines, 201312– license €na to CAP cell lines for expression of AAV vectors |
2013-12-19 |
| Boehringer–Circuit Therapeutics: drug target discovery, 201312– collab research €na 3y in field of psychiatric disorders |
2013-12-18 |
| Merck (DE)–CNIO: ATR kinase inhibitor, 201312– license excl rights to develop + commercialise ATR kinase inhibitors to Merck Serono |
2013-12-18 |
| Structural Genomics Consortium–Bayer: epigenetics, 201312– collab Bayer HealthCare joins SGC as new member |
2013-12-18 |
| Emergent BioSolutions–Minapharm: AGE1.CR cell line, 201312– license expansion €na broad non-excl commercial multi-product from ProBioGen |
2013-12-17 |
| Automation Partnership–Sartorius: investment, 201310–201312 acquisition €33m in cash of TAP Biosystems Group plc by Sartorius Stedim Biotech GmbH |
2013-12-16 |
| Pfizer–Siemens: companion diagnostics, 201312– collab developm + commercialisation master agreement w Siemens Healthcare Diagnostics Inc |
2013-12-16 |
| Strüngmann Group–Formycon: biosimilar, 201312– license ww excl to Lucentis biosimilar FYB201 to Santo Holding GmbH |
2013-12-12 |
| Roche–Prothena: therapeutic antibodies, 201312– collab ww co-develpm + co-promotion up to $600m + royalties ABs against Parkinson’s |
2013-12-11 |
| Covagen–SEVERAL: investment, 201312 tranched Series B CHF42m with option to obtain additional CHF14m led by new investor Gimv |
2013-12-09 |
| Biocartis–VIB: molecular diagnostics cancer test, 201312– license €na microsatellite instability (MSI) biomarkers from VIB for cancer tests |
2013-12-06 |
| Bayer–Druggability Technologies: drug delivery technology, 201312– collab multi-year to deploy Super-API platform to Bayer HealthCare molecules |
2013-12-05 |
| FN Semillas–Bayer: investment, 201312 acquisition €na by Bayer CropScience |
2013-12-05 |
| Sonic Healthcare–Ariosa Diagnostics: Harmony Prenatal Test, 201312 supply existent Sonic Healthcare offers test via TDL in the UK |
2013-12-05 |
| Sonic Healthcare–Ariosa Diagnostics: Harmony Prenatal Test, 201312– supply Sonic Healthcare will offer test via Bioscientia in Germany |
2013-12-05 |
| Euroimmun–Mecklenburg-Vorpommern (govt): grant, 201312– grant €3.15m to support total Euroimmun €14m investment to expand Dassow facility |
2013-12-04 |
| Roche–Molecular Partners: DARPins, 201312–201507 collab + license CHF55m upfront + CHF1b milestones + royalites cancer DARPin-toxin TERMINATED 7/15 |
2013-12-04 |
| Thermo Fisher–SEVERAL: credit, 201312 sale $1b 4.15% Senior Notes due 2024 to part-finance Life Technologies acquisition |
2013-12-04 |
| Thermo Fisher–SEVERAL: credit, 201312 sale $400m 5.3% Senior Notes due 2044 to part-finance Life Technologies acquisition |
2013-12-04 |
| Thermo Fisher–SEVERAL: credit, 201312 sale $900m 1.3% Senior Notes due 2017 to part-finance Life Technologies acquisition |
2013-12-04 |
| Thermo Fisher–SEVERAL: credit, 201312 sale $900m 2.4% Senior Notes due 2019 to part-finance Life Technologies acquisition |
2013-12-04 |
| Pfizer–Protagen: biomarker discovery services, 201312– collab use SeroTag process to identify markers for autoimmune drug developm |
2013-12-03 |
| Sigma-Aldrich–Glantreo: LC column technology, 201312 collab developm + license Ecoprous silica manufacturing process |
2013-12-03 |
| Telormedix–SEVERAL: investment, 201312 financing round Series B extension CHF6m ($6.6m) from existing investors Aravis Venture + ProQuest Investments |
2013-12-02 |
| Paion–Capital Ventures International: investment, 201312–201402 private placement €6.17 acquisition 2.55m new shares in 2 tranches by CVI |
2013-12-01 |
| TocopheRx–Merck (DE): investment, 201312 seed financing $3.2m from MS Ventures for spin-off from Merck Serono |
2013-12-01 |
| Algeta–Bayer: investment, 201311– acquisition proposal by Bayer NOK362/share valuing Algeta equity at €2.1b |
2013-11-26 |
| Gilde Investment–SEVERAL: investment, 201311 final close of €145m Gilde Healthcare III fund |
2013-11-26 |
| R-Pharm–Paion: remimazolam, 201310– license excl €1m upfront + €3m milestones + royalties for developm + manuf + marketing in Russia + CIS |
2013-11-26 |
| R-Pharm–Paion: remimazolam, 201311– license €1m upfront + €3m milestones + royalties for developm + marketing in Turkey to TR-Pharm |
2013-11-26 |
| Eloxx Pharmaceuticals–SEVERAL: investment, 201311 initial closing of 1st financing round with Roche + Pontifax |
2013-11-21 |
| Boehringer–Galapagos: drug discovery, 201311– supply integrated drug discovery services by BioFocus to undisclosed Boehringer target |
2013-11-20 |
| Definiens–Affect: public relations, 201311 service existent by Affect Inc |
2013-11-20 |
| GAS GmbH–Imspex: investment, 201311 acquisition of 100% of G.A.S. by Imspex Diagnostics Ltd |
2013-11-20 |
| Global Bioenergies–Germany (govt): grant, 201311– BMBF grant €5.7m for Global Bioenergies GmbH within BioEconomy programme |
2013-11-20 |
| Merck (DE)–Biopharm: therapeutic protein, 201311– collab €na r+d biopharmaceutical for osteoarthritis with Merck Serono |
2013-11-20 |
| Metamark Genetics–Definiens: image analysis s/w, 201311– collab + supply multi-year agreem to use Cognition Network Technology with ProMark test |
2013-11-20 |
| CI3 Cluster–AbbVie: personalised immunotherapy, 201311 collab existent AbbVie Deutschland GmbH & Co KG is cluster partner |
2013-11-19 |
| CI3 Cluster–Bayer: personalised immunotherapy, 201311 collab existent Bayer Vital GmbH is cluster partner |
2013-11-19 |
| CI3 Cluster–Biopharm: personalised immunotherapy, 201311 collab existent PW Technologies GmbH is cluster partner |
2013-11-19 |
| CI3 Cluster–Dr Falk Pharma: personalised immunotherapy, 201311 collab existent Dr Falk Pharma GmbH is cluster partner |
2013-11-19 |
| CI3 Cluster–GenXPro: personalised immunotherapy, 201311 collab existent GenXPro GmbH is cluster partner |
2013-11-19 |
| CI3 Cluster–Infraserv Höchst: personalised immunotherapy, 201311 collab existent Infraserv GmbH & Co Hoechst KG is cluster partner |
2013-11-19 |
| CI3 Cluster–itechpartners: personalised immunotherapy, 201311 collab existent itechpartners – Dr Rainer Wessel is cluster partner |
2013-11-19 |
| CI3 Cluster–Medatixx: personalised immunotherapy, 201311 collab existent Medatixx GmbH & Co KG is cluster partner |
2013-11-19 |
| CI3 Cluster–Medesso: personalised immunotherapy, 201311 collab existent Medesso GmbH is cluster partner |
2013-11-19 |
| CI3 Cluster–Molekularpathologie Trier: personalised immunotherapy, 201311 collab existent ProteoPath GbR is cluster partner |
2013-11-19 |
| CI3 Cluster–thinXXS Microtechnology: personalised immunotherapy, 201311 collab existent thinXXS Microtechnology AG is cluster partner |
2013-11-19 |
| Scopis–High-Tech Gründerfonds: investment, 201311 financing round Series A incl returning investor HTGF |
2013-11-19 |
| Scopis–SEVERAL: investment, 201311 financing round Series A from HTGF + VC Fonds Technologie Berlin + Falk Strascheg + Fraunhofer |
2013-11-19 |
| Cambridge Bioscience–InSphero: cell culture technology, 201311– distribution excl of InSphero 3D cell culture products + services in the UK |
2013-11-18 |
| Strüngmann Group–SEVERAL: investment, 201311 Ganymed financing round Series E €45m from existing investors ATS + MIG Fond + FCPB Gany GmbH |
2013-11-18 |
| CSM Instruments–Anton Paar: investment, 201311 acquisition of CSM Instruments SA |
2013-11-15 |
| Merck (DE)–BeiGene: cancer drug, 201311– license ww + collab co-developm + commercialisation of PARP inhibitor BeiGene-290 by Merck Serono |
2013-11-13 |
| Qiagen–Maverix Biomics: bioinformatics, 201311– collab €na product integration + co-marketing of Ingenuity iReport + Maverix Analytic Platform |
2013-11-13 |
| R-Biopharm–Candor Bioscience: immunoassays, 201311– strategic alliance in the area of companion diagnostics |
2013-11-13 |
| Roche–Immatics: cancer immunotherapy, 201311– strategic r+d collab €17m upfront + research funding + >€1b milestones to develop cancer vaccines |
2013-11-13 |
| Coral BioNet–Wacker: investment, 201311– acquisition 100% of Scil Proteins Production GmbH by Wacker Biotech GmbH from BioNet Ventures GmbH |
2013-11-12 |
| MeVis–PERSON: investment, 201311 shareholding of voting rights of Carl JG Evertsz has fallen to 14.995% |
2013-11-11 |
| Novartis–Grifols: investment, 201311–201401 acquisition $1.675b of blood transfusion diagnostis unit by Grifols |
2013-11-11 |
| JnJ–Evotec: drug discovery services, 201311– collab drug target discovery for Alzheimer drugs with JnJ Innovation Centre California |
2013-11-08 |
| Auven Therapeutics–Five Prime: human antibodies, 201311– license excl €na to develop cancer ADCs to ADC Therapeutics |
2013-11-05 |
| Biocartis–SEVERAL: investment, 201311 financing round Series E €30m from existing investors |
2013-11-05 |
| Midatech–SEVERAL: investment, 201311 financing round £10m led by Ippon Capital SA with £7.6m plus existing investors |
2013-11-05 |
| Hookipa–BioMedPartners: investment, 201311 financing round Series B totalling €20m incl new + co-investor BioMedPartners |
2013-11-04 |
| Hookipa–Boehringer: investment, 201311 financing round Series B totalling €20m incl new + co-investor BIVF |
2013-11-04 |
| Hookipa–Forbion: investment, 201311 financing round Series B totalling €20m incl co-lead + returning investor Forbion Capital Partners |
2013-11-04 |
| Hookipa–SEVERAL: investment, 201311 financing round Series B €20m led by Sofinnova Partners + Forbion Capital Partners |
2013-11-04 |
| Hookipa–Sofinnova: investment, 201311 financing round Series B totalling €20m incl co-lead + returning investor Sofinnova Partners |
2013-11-04 |
| Hookipa–Takeda: investment, 201311 financing round Series B totalling €20m incl new + co-investor Takeda Ventures |
2013-11-04 |
| Merck (DE)–Kadimastem: drug discovery services, 201311– collab MOU drug screening + discovery for neurodegenerative disesases Merck Serono |
2013-11-04 |
| Strüngmann Group–4SC: drug discovery services, 201311– collab discovery + optimis small molecule anti-infectives by 4SC Discovery+Crelux for AiCuris |
2013-11-04 |
| Thermo Fisher–Univ Utrecht: mass spectrometry, 201311– collab developm applications + appointm of A Makarov as Professor |
2013-11-04 |
| AlBioTex project–Germany (govt): grant, 201311– BMBF co-funding for research project on microbial production of biopolymers for medtech + textiles |
2013-11-01 |
| DISCO project–EU (govt): grant, 201311–201710 FP7 grant €6.5m to develop bioactive compound extraction procedures |
2013-11-01 |
| m2p-labs–SEVERAL: investment, 201311 3rd financing round Fidura Private Equity Fonds + HTGF |
2013-11-01 |
| CRM Clinical Trials–Venn Life Sciences: investment, 201310 acquisition €0.6m in shares ANNOUNCED |
2013-10-31 |
| Merck (DE)–Max Planck: drug discovery services, 201310– collab 5y strategic partnership of Merck Serono with Lead Discovery Center GmbH |
2013-10-31 |
| Ako med–Curetis: Unyvero system, 201310 distribution existent Ako med doo is distributor in countries of former Yugoslavia for system + cartridges |
2013-10-30 |
| BioLine (RU)–Curetis: Unyvero system, 201310 distribution existent BioLine LLC is Russian distribution partner for system + cartridges |
2013-10-30 |
| Sanofi–Genedata: bioinformatics, 201310– supply Genedata Biologics data management platform will be used for biologcics sreening |
2013-10-30 |
| BioChain–Epigenomics: molecular diagnostics, 201310– broad strategic collaboration expanding prior license agreement for China |
2013-10-28 |
| Cell Signaling Technology–RainDance: RainDrop Digital PCR System, 201310– distribution by BIOKÉ in Germany + Benelux |
2013-10-28 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
1 2 3 ... 33 34 35 ... 53 54 55 
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
